Posted by Michael Wonder on 30 May 2022
ViiV Healthcare commits to grant voluntary licence for patents relating to cabotegravir long-acting for PrEP to Medicines Patent Pool
27 May 2022 - ViiV Healthcare and MPP are actively negotiating voluntary licensing terms to help widen access to innovative HIV prevention measure.
ViiV Healthcare has today announced that it is committing to license its patents relating to cabotegravir long-acting for HIV pre-exposure prophylaxis (PrEP) and is entering into negotiation on voluntary licensing terms with the UN backed Medicines Patent Pool.
ViiV Healthcare and the Medicines Patent Pool are working to agree terms and execute a voluntary licence as quickly as possible to help enable at scale access to long-acting cabotegravir for PrEP in low and middle income countries.
